Resolution of Inflammation in Retinal Disorders: Briefly the State.
annexins
galectins
inflammation
lipoxins
maresins
pro-resolving mediators
protectins
resolvins
retinopathy
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
19 Apr 2022
19 Apr 2022
Historique:
received:
23
03
2022
revised:
13
04
2022
accepted:
16
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
18
5
2022
Statut:
epublish
Résumé
The most frequent retinal diseases, such as diabetic retinopathy, age-related macular degeneration and posterior uveitis, are underlined by oxidative stress or aging-induced retinal inflammation, which contributes to vision impairing or loss. Resolution of inflammation is emerging as a critical phase able to counteract the inflammatory process leading to the progression of retinal damage. Particularly, pro-resolving mediators (PMs) play a key role in the modulation of inflammatory exudates and could be considered a new target to be investigated in different inflammatory-autoimmune pathologies. Here, we highlight the most recent studies concerning the role of the main PMs (lipoxins, resolvins, prtectins, maresins and annexins) in retinal inflammation, in order to collect the best evidence in the field of inflammatory retinal damage resolution and to propose novel pharmacological approaches in the management of the most common retinal diseases.
Identifiants
pubmed: 35562891
pii: ijms23094501
doi: 10.3390/ijms23094501
pmc: PMC9100636
pii:
doi:
Substances chimiques
Inflammation Mediators
0
Lipoxins
0
Docosahexaenoic Acids
25167-62-8
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : ITALIAN MINISTRY OF EDUCATION, UNIVERSITY AND RESEARCH
ID : PRIN-2017TSHBXZ
Organisme : ROMANIAN MINISTRY OF RESEARCH, INNOVATION AND DIGITIZATION, CNCS/CCCDI - UEFISCDI
ID : PN-III-P4-ID-PCE-2020-1772, within PNCDI III.
Références
J Cell Physiol. 2021 Jan;236(1):340-353
pubmed: 32510663
Mol Vis. 2009 Jun 17;15:1231-42
pubmed: 19536308
Front Pharmacol. 2020 Mar 06;11:235
pubmed: 32210819
J Cell Physiol. 2020 May;235(5):4256-4267
pubmed: 31612492
Trends Neurosci. 2011 Nov;34(11):599-609
pubmed: 21963090
Mitochondrion. 2017 Sep;36:114-123
pubmed: 28549843
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18232-7
pubmed: 24108355
Biochem Biophys Res Commun. 2019 Aug 27;516(3):900-906
pubmed: 31272712
Trends Neurosci. 2006 May;29(5):263-71
pubmed: 16580739
Int J Mol Med. 2018 Jul;42(1):13-20
pubmed: 29693113
Front Pharmacol. 2019 Nov 29;10:1363
pubmed: 31849644
Mol Neurobiol. 2010 Jun;41(2-3):367-74
pubmed: 20467837
J Clin Invest. 2004 Jan;113(1):38-48
pubmed: 14702107
Transl Vis Sci Technol. 2017 Oct 05;6(5):10
pubmed: 29057162
Zhonghua Yan Ke Za Zhi. 2013 Jul;49(7):642-8
pubmed: 24257362
Curr Opin Ophthalmol. 2018 May;29(3):267-274
pubmed: 29521875
Brain Pathol. 2005 Apr;15(2):159-66
pubmed: 15912889
Autoimmun Rev. 2017 Dec;16(12):1254-1264
pubmed: 29037906
Int J Inflam. 2013;2013:281981
pubmed: 23365785
J Clin Invest. 2017 Dec 1;127(12):4403-4414
pubmed: 29106385
Ann Transl Med. 2021 Aug;9(15):1249
pubmed: 34532386
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3613-20
pubmed: 19443724
Prostaglandins Other Lipid Mediat. 2013 Dec;107:85-94
pubmed: 23954858
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14682-7
pubmed: 12391305
Int J Biochem Cell Biol. 2021 Jan;130:105881
pubmed: 33181315
Biomed Pharmacother. 2020 Oct;130:110591
pubmed: 32763821
Mediators Inflamm. 2015;2015:126408
pubmed: 26180376
Trans Am Clin Climatol Assoc. 2015;126:144-55
pubmed: 26330668
J Lipid Res. 2010 Aug;51(8):2018-31
pubmed: 20382842
Chin Med J (Engl). 2013;126(11):2109-15
pubmed: 23769567
Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13158-63
pubmed: 17670935
Front Pharmacol. 2019 Jan 17;9:1582
pubmed: 30705632
Clin Rev Allergy Immunol. 2020 Feb;58(1):82-91
pubmed: 31267470
Mol Pharmacol. 2008 Jul;74(1):154-61
pubmed: 18413658
Lancet. 2018 Sep 29;392(10153):1147-1159
pubmed: 30303083
J Exp Med. 2000 Oct 16;192(8):1197-204
pubmed: 11034610
Exp Eye Res. 2016 Jan;142:71-5
pubmed: 26675403
Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4866-81; biography 4864-5
pubmed: 17962433
Exp Diabetes Res. 2007;2007:51837
pubmed: 17641742
Front Pharmacol. 2021 May 17;12:687495
pubmed: 34079467
FASEB J. 2019 Jan;33(1):373-387
pubmed: 29975570
Inflammation. 2022 Feb;45(1):414-427
pubmed: 34595678
Front Pharmacol. 2021 Sep 17;12:718902
pubmed: 34603029
Front Pharmacol. 2020 May 08;11:612
pubmed: 32457616
Metabolism. 2015 Sep;64(9):958-66
pubmed: 26004392
J Inflamm Res. 2015 Sep 30;8:181-92
pubmed: 26457057
Prostaglandins Leukot Essent Fatty Acids. 2010 Jan;82(1):27-34
pubmed: 19931440
J Biol Chem. 2009 Jun 26;284(26):17877-82
pubmed: 19403949
Trans Am Ophthalmol Soc. 1980;78:206-25
pubmed: 6167054
ScientificWorldJournal. 2010 Jun 01;10:1029-47
pubmed: 20526534
Int J Oncol. 2018 Jan;52(1):5-18
pubmed: 29115416
Mol Vis. 2010 Mar 02;16:320-9
pubmed: 20216940
Eur J Pharmacol. 2016 Aug 15;785:133-143
pubmed: 25987424
Chin Med J (Engl). 2010 Mar 20;123(6):713-21
pubmed: 20368092
J Exp Med. 2002 Oct 21;196(8):1025-37
pubmed: 12391014
Mediators Inflamm. 2018 Feb 20;2018:2380319
pubmed: 29674943
J Proteome Res. 2009 Mar;8(3):1255-62
pubmed: 19125585
Arch Ophthalmol. 2008 Feb;126(2):219-25
pubmed: 18268213
Br J Pharmacol. 2009 Oct;158(4):960-71
pubmed: 19594757
J Clin Invest. 2019 Dec 2;129(12):5294-5311
pubmed: 31657786
Am J Ophthalmol. 2002 Sep;134(3):411-31
pubmed: 12208254
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):858-869
pubmed: 29490339
Adv Exp Med Biol. 2016;854:385-91
pubmed: 26427436
Biochim Biophys Acta. 2015 Apr;1851(4):397-413
pubmed: 25139562
Int J Inflam. 2013;2013:724648
pubmed: 24109539
Nat Med. 2007 Jul;13(7):868-873
pubmed: 17589522
Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8491-6
pubmed: 15152078
Int J Mol Sci. 2021 Jun 11;22(12):
pubmed: 34208040
J Immunol. 2013 Jun 15;190(12):6478-87
pubmed: 23686496
Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13152-7
pubmed: 17670936
PLoS One. 2014 May 16;9(5):e97302
pubmed: 24837086
Mediators Inflamm. 2015;2015:149381
pubmed: 25684860
Physiol Rev. 2002 Apr;82(2):331-71
pubmed: 11917092